Authors’ financial disclosures can be a thorny issue for scientific journals. There’s often confusion over just what should be listed as a conflict of interest, and when relationships are revealed after papers are published, lack of disclosure sometimes leads to corrections.
For example, the Journal of Cell Science recently published this: Continue reading Coming clean: A major figure in cardiology publishes a lengthy conflict of interest correction in JAMA
Former Duke oncology researcher Anil Potti has retracted another paper, marking his ninth withdrawal. The notice in the Journal of Clinical Oncology (JCO) reads:
“An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer” by Holly K. Dressman, Andrew Berchuck, Gina Chan, Jun Zhai, Andrea Bild, Robyn Sayer, Janiel Cragun, Jennifer Clarke, Regina S. Whitaker, LiHua Li, Jonathan Gray, Jeffrey Marks, Geoffrey S. Ginsburg, Anil Potti, Mike West, Joseph R. Nevins, and Johnathan M. Lancaster (J Clin Oncol 25:517-525, 2007)
The majority of the authors wish to retract this article because Continue reading Anil Potti and colleagues retract ninth paper, this one in JCO
The editor of a new journal that published a paper that has been met with disbelief by many in the blogoshpere — and those are the polite reactions — has posted a narrative about how the paper came to appear in his journal. Retraction Watch readers may recall that Case Western, home to the paper’s author, Erik Andrulis, retracted its press release about the work. Several of the journal’s editorial board members have resigned over it.
Life’s editor, Shu-Kun Lin, writes that there was a switch in editors: Continue reading Editor who published Andrulis paper tries to explain how it happened
Is self-plagiarism — perhaps best referred to as duplication of your own work — a big problem in nanotechnology research?
The American Chemical Society (ACS) Nano journal retracted a study, “Retraction of Nanoembossing Induced Ferroelectric Lithography on PZT Films for Silver Particle Patterning,” late last month because of such duplication:
This article was withdrawn at the request of the Editor-in-Chief, with agreement by the authors, due to unacceptable redundant text and figures with a previously published article by the same authors (Langmuir 2011, 27, 5167-5170. DOI: 10.1021/la200377b).
This wasn’t the first such retraction for the journal. In May, they retracted “Conductance Preservation of Carbene-Functionalized Metallic Single-Walled Carbon Nanotubes for the same reason:” Continue reading No small matter: ACS Nano journal growing alarmed by self-plagiarism
Last week, we covered the case of Michael W. Miller, a former department chair at the State University of New York (SUNY) Upstate who was forced to retract a paper in the Journal of Neurochemistry after a university investigation found he had committed misconduct.
We figured more retractions might be on the way, so we weren’t surprised when a commenter informed us earlier today of “very interesting and odd retraction letter.” Miller has had at least one other retraction, it turns out, this one in Developmental Neuroscience for 2009’s “Lability of Neuronal Lineage Decisions Is Revealed by Acute Exposures to Ethanol.” Here’s the notice, published online on January 19: Continue reading Second retraction for former SUNY Upstate department chair found guilty of misconduct
Last week, we reported on the retraction of a paper in the Journal of Biological Chemistry (JBC) that had one of the journal’s typically inscrutable retraction notices.:
This article has been withdrawn by the authors.
Late last week, we heard back from corresponding author Takashi Tsuji by email. It turns out one of our commenters had basically figured out what was wrong. It was, as seems to often be the case lately in retractions we cover, troubles with Western blots: Continue reading Tsuji explains why JBC paper was retracted: Western blot problems
Late last year, we published an invited commentary in Nature calling for science to more formally embrace post-publication peer review, and stop fetishizing the published paper. One of the models we cited was Faculty of 1000 (F1000), “in which experts flag important papers in their field.”
So it’s not surprising that F1000 is announcing today that they’re launching a new journal, F1000 Research,
intended to address three major issues afflicting scientific publishing today: timely dissemination of research, peer review and sharing of data.
The journal will publish all submissions immediately, “beyond an initial sanity check:” Continue reading An arXiv for all of science? F1000 launches new immediate publication journal
Stefano Fiorucci, a gastroenterology researcher at the University of Perugia in Italy, has been indicted for fraud and embezzlement, after a university investigation found that he had manipulated images in papers that he used to win about 2 million Euros in grant funding.
The case, which has so far resulted in four retractions and nine Expressions of Concern, has dragged on for several years. The trial is scheduled for July. It’s the first time that embezzlement charges have been brought against a scientist found to have committed fraud, according to reports in Umbria 24 and the Umbria Journal.
Fiorucci’s attorney, Stefano Bagianti, told Umbria 24 that there was Continue reading University of Perugia researcher faces trial for embezzlement, fraud following 13 retractions and Expressions of Concern
The wild and woolly saga of the paper that claims to solve “the puzzle of the origin and evolution of cellular life in the universe” continues.
Yesterday, Ivan wrote on his Tumblr about Case Western’s Erik D. Andrulis‘ paper, “Theory of the Origin, Evolution, and Nature of Life:” Continue reading Case Western explains why it withdrew press release about Andrulis origin of life paper
The authors of a paper published last September in Blood about alleged links between certain genes and Hodgkin’s lymphoma have retracted it, after realizing they’d made mistakes in their calculations.
The retraction notice for “Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups,” dated January 20 and signed by all of the authors, clearly explains what went wrong, taking pains to note that there was no misconduct involved: Continue reading Errors force retraction of Blood paper on genetics of Hodgkin’s lymphoma